{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:50:11Z","timestamp":1780775411911,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s42000-023-00479-x","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T10:02:46Z","timestamp":1692612166000},"page":"595-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The effect of radioiodine therapy on blood cell count in patients with differentiated thyroid cancer"],"prefix":"10.1007","volume":"22","author":[{"given":"Ahmet Numan","family":"Demir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Sulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhat","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guldana","family":"Zulfaliyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oznur Aydin","family":"Atar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahida","family":"Valikhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulin","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande Mefkure","family":"Ozkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taner","family":"Damci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1089-623X","authenticated-orcid":false,"given":"Mustafa Sait","family":"Gonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"issue":"1","key":"479_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"issue":"6","key":"479_CR2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1530\/eje.1.02158","volume":"154","author":"F Pacini","year":"2006","unstructured":"Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium [published correction appears in Eur J Endocrinol 155(2):385]. Eur J Endocrinol 154(6):787\u2013803. https:\/\/doi.org\/10.1530\/eje.1.02158","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"479_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","volume":"97","author":"EL Mazzaferri","year":"1994","unstructured":"Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer [published correction appears in Am J Med 98(2):215]. Am J Med 97(5):418\u2013428. https:\/\/doi.org\/10.1016\/0002-9343(94)90321-2","journal-title":"Am J Med"},{"issue":"2","key":"479_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.semnuclmed.2010.11.002","volume":"41","author":"SJ Goldsmith","year":"2011","unstructured":"Goldsmith SJ (2011) To ablate or not to ablate: issues and evidence involved in 131I ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma. Semin Nucl Med 41(2):96\u2013104. https:\/\/doi.org\/10.1053\/j.semnuclmed.2010.11.002","journal-title":"Semin Nucl Med"},{"issue":"12","key":"479_CR5","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1089\/thy.2006.16.1229","volume":"16","author":"J Jonklaas","year":"2006","unstructured":"Jonklaas J, Sarlis NJ, Litofsky D et al (2006) Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16(12):1229\u20131242. https:\/\/doi.org\/10.1089\/thy.2006.16.1229","journal-title":"Thyroid"},{"issue":"8","key":"479_CR6","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante C, Haddy N, Baudin E et al (2006) Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91(8):2892\u20132899. https:\/\/doi.org\/10.1210\/jc.2005-2838","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"479_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/105072503321582060","volume":"13","author":"SJ Mandel","year":"2003","unstructured":"Mandel SJ, Mandel L (2003) Radioactive iodine and the salivary glands. Thyroid 13(3):265\u2013271. https:\/\/doi.org\/10.1089\/105072503321582060","journal-title":"Thyroid"},{"issue":"12","key":"479_CR8","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.1210\/jc.2002-020210","volume":"87","author":"RT Kloos","year":"2002","unstructured":"Kloos RT, Duvuuri V, Jhiang SM, Cahill KV, Foster JA, Burns JA (2002) Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. J Clin Endocrinol Metab 87(12):5817\u20135820. https:\/\/doi.org\/10.1210\/jc.2002-020210","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"479_CR9","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.4158\/EP10170.RA","volume":"16","author":"SL Hyer","year":"2010","unstructured":"Hyer SL, Newbold K, Harmer CL (2010) Early and late toxicity of radioiodine therapy: detection and management. Endocr Pract 16(6):1064\u20131070. https:\/\/doi.org\/10.4158\/EP10170.RA","journal-title":"Endocr Pract"},{"issue":"6","key":"479_CR10","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.surg.2011.12.019","volume":"151","author":"BH Lang","year":"2012","unstructured":"Lang BH, Wong IO, Wong KP, Cowling BJ, Wan KY (2012) Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy. Surgery 151(6):844\u2013850. https:\/\/doi.org\/10.1016\/j.surg.2011.12.019","journal-title":"Surgery"},{"key":"479_CR11","first-page":"85","volume":"4","author":"TP Haynie","year":"1963","unstructured":"Haynie TP, Beierwaltes WH (1963) Hematologic changes observed following I-131 therapy for thyroid carcinoma. J Nucl Med 4:85\u201391","journal-title":"J Nucl Med"},{"issue":"8","key":"479_CR12","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3109\/02841869009091796","volume":"29","author":"N Keldsen","year":"1990","unstructured":"Keldsen N, Mortensen BT, Hansen HS (1990) Haematological effects from radioiodine treatment of thyroid carcinoma. Acta Oncol 29(8):1035\u20131039. https:\/\/doi.org\/10.3109\/02841869009091796","journal-title":"Acta Oncol"},{"issue":"2","key":"479_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s002590000420","volume":"28","author":"T Petrich","year":"2001","unstructured":"Petrich T, Widjaja A, Musholt TJ et al (2001) Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age. Eur J Nucl Med 28(2):203\u2013208. https:\/\/doi.org\/10.1007\/s002590000420","journal-title":"Eur J Nucl Med"},{"issue":"19","key":"479_CR14","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1001\/archinte.1996.00440180017002","volume":"156","author":"PA Singer","year":"1996","unstructured":"Singer PA, Cooper DS, Daniels GH et al (1996) Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 156(19):2165\u20132172","journal-title":"Arch Intern Med"},{"issue":"10","key":"479_CR15","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s00259-008-0883-1","volume":"35","author":"M Luster","year":"2008","unstructured":"Luster M, Clarke SE, Dietlein M et al (2008) Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 35(10):1941\u20131959. https:\/\/doi.org\/10.1007\/s00259-008-0883-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"479_CR16","doi-asserted-by":"publisher","unstructured":"American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM et al. (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [published correction appears in Thyroid 20(8):942. Hauger, Bryan R [corrected to Haugen, Bryan R]] [published correction appears in Thyroid 20(6):674\u20135]. Thyroid 19(11):1167\u20131214. https:\/\/doi.org\/10.1089\/thy.2009.0110","DOI":"10.1089\/thy.2009.0110"},{"key":"479_CR17","doi-asserted-by":"publisher","unstructured":"Perrier ND, Brierley JD, Tuttle RM (2018) Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 68(1):55\u201363. https:\/\/doi.org\/10.3322\/caac.21439","DOI":"10.3322\/caac.21439"},{"key":"479_CR18","unstructured":"National Cancer Institute (2017) Common Terminology Criteria for Adverse Events (CTCAE v5.0) Washington, DC: National Cancer Institute, Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf. Accessed October 10, 2019"},{"issue":"10","key":"479_CR19","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1089\/thy.2008.0430","volume":"19","author":"E Molinaro","year":"2009","unstructured":"Molinaro E, Leboeuf R, Shue B et al (2009) Mild decreases in white blood cell and platelet counts are present one year after radioactive iodine remnant ablation. Thyroid 19(10):1035\u20131041. https:\/\/doi.org\/10.1089\/thy.2008.0430","journal-title":"Thyroid"},{"issue":"3","key":"479_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4158\/EP13172.OR","volume":"20","author":"RP Padovani","year":"2014","unstructured":"Padovani RP, Tuttle RM, Grewal R, Larson SM, Boucai L (2014) Complete blood counts are frequently abnormal 1 year after dosimetry-guided radioactive iodine therapy for metastatic thyroid cancer. Endocr Pract 20(3):213\u2013220. https:\/\/doi.org\/10.4158\/EP13172.OR","journal-title":"Endocr Pract"},{"issue":"10","key":"479_CR21","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1210\/jc.2015-2124","volume":"100","author":"HT Prinsen","year":"2015","unstructured":"Prinsen HT, Klein Hesselink EN, Brouwers AH et al (2015) Bone Marrow Function After (131)I Therapy in Patients With Differentiated Thyroid Carcinoma. J Clin Endocrinol Metab 100(10):3911\u20133917. https:\/\/doi.org\/10.1210\/jc.2015-2124","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"479_CR22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4274\/tjh.galenos.2021.2021.0092","volume":"38","author":"B S\u00f6nmez","year":"2021","unstructured":"S\u00f6nmez B, Bekta\u015f \u00d6, Erkut N, S\u00f6nmez M (2021) Assessment of Long-Term Hematologic Effects in Differentiated Thyroid Cancer Patients Treated with Radioactive Iodine. Turk J Haematol 38(4):306\u2013313. https:\/\/doi.org\/10.4274\/tjh.galenos.2021.2021.0092","journal-title":"Turk J Haematol"},{"key":"479_CR23","doi-asserted-by":"publisher","unstructured":"Hu T, Meng Z, Zhang G et al (2016) Influence of the first radioactive iodine ablation on peripheral complete blood count in patients with differentiated thyroid cancer. Medicine (Baltimore) 95(35):e4451. https:\/\/doi.org\/10.1097\/MD.0000000000004451","DOI":"10.1097\/MD.0000000000004451"},{"issue":"12","key":"479_CR24","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1507\/endocrj.EJ20-0242","volume":"67","author":"W Yi","year":"2020","unstructured":"Yi W, Kim BH, Kim M et al (2020) Short-term bone marrow suppression in differentiated thyroid cancer patients after radioactive iodine treatment. Endocr J 67(12):1193\u20131198. https:\/\/doi.org\/10.1507\/endocrj.EJ20-0242","journal-title":"Endocr J"},{"key":"479_CR25","doi-asserted-by":"publisher","unstructured":"Yamashita K, Morimoto S, Kimura S et al (2021) Transient Leukopenia After Radioactive Iodine Treatment in Patients With Graves' Disease: A Retrospective Cohort Study. J Endocr Soc 5(5):bvab039. https:\/\/doi.org\/10.1210\/jendso\/bvab039","DOI":"10.1210\/jendso\/bvab039"},{"issue":"5","key":"479_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/thy.2018.0423","volume":"29","author":"H Duskin-Bitan","year":"2019","unstructured":"Duskin-Bitan H, Leibner A, Amitai O et al (2019) Bone-Marrow Suppression in Elderly Patients Following Empiric Radioiodine Therapy: Real-Life Data. Thyroid 29(5):683\u2013691. https:\/\/doi.org\/10.1089\/thy.2018.0423","journal-title":"Thyroid"},{"key":"479_CR27","doi-asserted-by":"publisher","unstructured":"Dong P, Wang L, Huang R, Li L (2020) Bone marrow suppression in pediatric patients with differentiated thyroid cancer following empirical radioiodine therapy. Medicine (Baltimore) 99(31):e21398. https:\/\/doi.org\/10.1097\/MD.0000000000021398","DOI":"10.1097\/MD.0000000000021398"},{"key":"479_CR28","doi-asserted-by":"publisher","unstructured":"Warny M, Helby J, Nordestgaard BG, Birgens H, Bojesen SE (2018) Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study. PLoS Med 15(11):e1002685. https:\/\/doi.org\/10.1371\/journal.pmed.1002685","DOI":"10.1371\/journal.pmed.1002685"},{"issue":"2","key":"479_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0883-2897(89)90188-8","volume":"16","author":"SM Larson","year":"1989","unstructured":"Larson SM, Raubitschek A, Reynolds JC et al (1989) Comparison of bone marrow dosimetry and toxic effect of high dose 131I-labeled monoclonal antibodies administered to man. Int J Rad Appl Instrum B 16(2):153\u2013158. https:\/\/doi.org\/10.1016\/0883-2897(89)90188-8","journal-title":"Int J Rad Appl Instrum B"},{"issue":"3","key":"479_CR30","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3892\/mco.2015.499","volume":"3","author":"S Monzen","year":"2015","unstructured":"Monzen S, Mariya Y, Wojcik A et al (2015) Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients. Mol Clin Oncol 3(3):692\u2013698. https:\/\/doi.org\/10.3892\/mco.2015.499","journal-title":"Mol Clin Oncol"},{"issue":"6","key":"479_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/s0301-472x(02)00802-0","volume":"30","author":"N Dainiak","year":"2002","unstructured":"Dainiak N (2002) Hematologic consequences of exposure to ionizing radiation. Exp Hematol 30(6):513\u2013528. https:\/\/doi.org\/10.1016\/s0301-472x(02)00802-0","journal-title":"Exp Hematol"},{"issue":"5","key":"479_CR32","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/cen.14563","volume":"95","author":"P Dong","year":"2021","unstructured":"Dong P, Qu Y, Yang L, Xiao L, Huang R, Li L (2021) Outcomes after radioiodine ablation in patients with thyroid cancer: Long-term follow-up of a Chinese randomized clinicaltrial. Clin Endocrinol (Oxf) 95(5):782\u2013789. https:\/\/doi.org\/10.1111\/cen.14563","journal-title":"Clin Endocrinol (Oxf)"},{"key":"479_CR33","doi-asserted-by":"publisher","unstructured":"Hay ID, Kaggal S, Thompson GB (2022) Radioiodine remnant ablation in stage I adult papillary thyroid carcinoma: does it improve postoperative outcome?. Eur Thyroid J 11(4):e220084. https:\/\/doi.org\/10.1530\/ETJ-22-0084","DOI":"10.1530\/ETJ-22-0084"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-023-00479-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-023-00479-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-023-00479-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T01:12:42Z","timestamp":1700097162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-023-00479-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1007\/s42000-023-00479-x","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"27 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies with human participants followed the ethical standards of the institutional and\/or national research committee and the 1964 Declaration of Helsinki and its subsequent amendments or comparable ethical standards. The Ethics Committee of Istanbul University-Cerrahpa\u015fa approved the study (approval number: 474738).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Signed informed consent was obtained from all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no relevant financial or nonfinancial conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}